350 related articles for article (PubMed ID: 27654582)
1. Ultra-Low-Dose Ultrasound Molecular Imaging for the Detection of Angiogenesis in a Mouse Murine Tumor Model: How Little Can We See?
Wang S; Herbst EB; Mauldin FW; Diakova GB; Klibanov AL; Hossack JA
Invest Radiol; 2016 Dec; 51(12):758-766. PubMed ID: 27654582
[TBL] [Abstract][Full Text] [Related]
2. Targeted contrast-enhanced ultrasound imaging of angiogenesis in an orthotopic mouse tumor model of renal carcinoma.
Wei S; Fu N; Sun Y; Yang Z; Lei L; Huang P; Yang B
Ultrasound Med Biol; 2014 Jun; 40(6):1250-9. PubMed ID: 24613557
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound molecular imaging of VEGFR2 in a rat prostate tumor model using BR55.
Tardy I; Pochon S; Theraulaz M; Emmel P; Passantino L; Tranquart F; Schneider M
Invest Radiol; 2010 Oct; 45(10):573-8. PubMed ID: 20808233
[TBL] [Abstract][Full Text] [Related]
4. BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis.
Pochon S; Tardy I; Bussat P; Bettinger T; Brochot J; von Wronski M; Passantino L; Schneider M
Invest Radiol; 2010 Feb; 45(2):89-95. PubMed ID: 20027118
[TBL] [Abstract][Full Text] [Related]
5. US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice.
Willmann JK; Paulmurugan R; Chen K; Gheysens O; Rodriguez-Porcel M; Lutz AM; Chen IY; Chen X; Gambhir SS
Radiology; 2008 Feb; 246(2):508-18. PubMed ID: 18180339
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound Molecular Imaging of Angiogenesis Using Vascular Endothelial Growth Factor-Conjugated Microbubbles.
Wang J; Qin B; Chen X; Wagner WR; Villanueva FS
Mol Pharm; 2017 Mar; 14(3):781-790. PubMed ID: 28165246
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional ultrasound molecular imaging of angiogenesis in colon cancer using a clinical matrix array ultrasound transducer.
Wang H; Kaneko OF; Tian L; Hristov D; Willmann JK
Invest Radiol; 2015 May; 50(5):322-9. PubMed ID: 25575176
[TBL] [Abstract][Full Text] [Related]
8. The Use of Acoustic Radiation Force Decorrelation-Weighted Pulse Inversion for Enhanced Ultrasound Contrast Imaging.
Herbst EB; Unnikrishnan S; Wang S; Klibanov AL; Hossack JA; Mauldin FW
Invest Radiol; 2017 Feb; 52(2):95-102. PubMed ID: 27495188
[TBL] [Abstract][Full Text] [Related]
9. Low-Dose Molecular Ultrasound Imaging with E-Selectin-Targeted PBCA Microbubbles.
Spivak I; Rix A; Schmitz G; Fokong S; Iranzo O; Lederle W; Kiessling F
Mol Imaging Biol; 2016 Apr; 18(2):180-90. PubMed ID: 26391990
[TBL] [Abstract][Full Text] [Related]
10. Ultrasound Molecular Imaging of the Breast Cancer Neovasculature using Engineered Fibronectin Scaffold Ligands: A Novel Class of Targeted Contrast Ultrasound Agent.
Abou-Elkacem L; Wilson KE; Johnson SM; Chowdhury SM; Bachawal S; Hackel BJ; Tian L; Willmann JK
Theranostics; 2016; 6(11):1740-52. PubMed ID: 27570547
[TBL] [Abstract][Full Text] [Related]
11. Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent.
Anderson CR; Hu X; Zhang H; Tlaxca J; Declèves AE; Houghtaling R; Sharma K; Lawrence M; Ferrara KW; Rychak JJ
Invest Radiol; 2011 Apr; 46(4):215-24. PubMed ID: 21343825
[TBL] [Abstract][Full Text] [Related]
12. Microultrasound molecular imaging of vascular endothelial growth factor receptor 2 in a mouse model of tumor angiogenesis.
Rychak JJ; Graba J; Cheung AM; Mystry BS; Lindner JR; Kerbel RS; Foster FS
Mol Imaging; 2007; 6(5):289-96. PubMed ID: 18092513
[TBL] [Abstract][Full Text] [Related]
13. Quantitative ultrasound molecular imaging by modeling the binding kinetics of targeted contrast agent.
Turco S; Tardy I; Frinking P; Wijkstra H; Mischi M
Phys Med Biol; 2017 Mar; 62(6):2449-2464. PubMed ID: 28240217
[TBL] [Abstract][Full Text] [Related]
14. Assessment and monitoring tumor vascularity with contrast-enhanced ultrasound maximum intensity persistence imaging.
Pysz MA; Foygel K; Panje CM; Needles A; Tian L; Willmann JK
Invest Radiol; 2011 Mar; 46(3):187-95. PubMed ID: 21150790
[TBL] [Abstract][Full Text] [Related]
15. Targeted Ultrasound Contrast Imaging of Tumor Vasculature With Positively Charged Microbubbles.
Diakova GB; Du Z; Klibanov AL
Invest Radiol; 2020 Nov; 55(11):736-740. PubMed ID: 32569011
[TBL] [Abstract][Full Text] [Related]
16. scVEGF microbubble ultrasound contrast agents: a novel probe for ultrasound molecular imaging of tumor angiogenesis.
Anderson CR; Rychak JJ; Backer M; Backer J; Ley K; Klibanov AL
Invest Radiol; 2010 Oct; 45(10):579-85. PubMed ID: 20733505
[TBL] [Abstract][Full Text] [Related]
17. A triple-targeted ultrasound contrast agent provides improved localization to tumor vasculature.
Warram JM; Sorace AG; Saini R; Umphrey HR; Zinn KR; Hoyt K
J Ultrasound Med; 2011 Jul; 30(7):921-31. PubMed ID: 21705725
[TBL] [Abstract][Full Text] [Related]
18. Dual-Targeted Microbubbles Specific to Integrin αVβ3 and Vascular Endothelial Growth Factor Receptor 2 for Ultrasonography Evaluation of Tumor Angiogenesis.
Yuan HX; Wang WP; Wen JX; Lin LW; Exner AA; Guan PS; Chen XJ
Ultrasound Med Biol; 2018 Jul; 44(7):1460-1467. PubMed ID: 29706409
[TBL] [Abstract][Full Text] [Related]
19. Intra-Animal Comparison between Three-dimensional Molecularly Targeted US and Three-dimensional Dynamic Contrast-enhanced US for Early Antiangiogenic Treatment Assessment in Colon Cancer.
Wang H; Lutz AM; Hristov D; Tian L; Willmann JK
Radiology; 2017 Feb; 282(2):443-452. PubMed ID: 27490690
[TBL] [Abstract][Full Text] [Related]
20. VEGFR2-targeted molecular imaging in the mouse embryo: an alternative to the tumor model.
Denbeigh JM; Nixon BA; Hudson JM; Puri MC; Foster FS
Ultrasound Med Biol; 2014 Feb; 40(2):389-99. PubMed ID: 24342913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
